NR4A1 and breast cancer: Our studies in hormone receptor-positive BC models displaying low (T47D) or high (BT-474 and C4HD) levels of MErbB-2 revealed that when we induce NErbB-2 migration via stimulation with HRGβ1 or progestin, R2 is again able to block its nuclear migration.